Related Experiment Video
Updated: Oct 7, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
A Comprehensive Review Study on Glomerulonephritis Associated With Post-streptococcal Infection
Mustafa A Alhamoud1, Ibrahim Z Salloot1, Shamim S Mohiuddin2
1Medicine, College of Medicine, King Fahd Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, SAU.
Post-streptococcal glomerulonephritis (PSGN) is an immune-mediated kidney inflammation following Group A Streptococcus infections. Prompt antibiotic treatment of these infections is crucial for preventing PSGN complications like chronic kidney disease.
Area of Science:
- Nephrology
- Immunology
- Infectious Diseases
Background:
- Post-streptococcal glomerulonephritis (PSGN) is a significant cause of acute nephritis in children, triggered by specific Group A beta-hemolytic streptococci strains.
- This condition results from an immune complex-mediated inflammatory response within the glomeruli following skin or throat infections.
- Group A Streptococcus (GAS) is a major pathogen responsible for numerous deaths annually due to complications like rheumatic heart disease, rheumatic fever, and invasive infections.
Purpose of the Study:
- To elucidate the pathogenesis, diagnosis, and management of Post-streptococcal glomerulonephritis (PSGN).
- To highlight the role of Group A Streptococcus (GAS) infections in triggering PSGN.
- To emphasize the importance of early diagnosis and symptomatic management of PSGN.
Main Methods:
- Diagnosis involves laboratory tests such as microscopy and urinalysis.
- Imaging studies may be utilized to identify complications like pulmonary congestion and chronic kidney disease.
- The study reviews the immunologic mechanism involving antigen-antibody and complement system formation leading to glomerular injury.
Main Results:
- PSGN is characterized by glomerular inflammation due to deposited immune complexes following a GAS infection.
- Clinical manifestations align with nephritic syndrome.
- Untreated PSGN can progress to chronic kidney disease.
Conclusions:
- Effective management of PSGN is primarily symptomatic.
- Preventing PSGN hinges on the timely and adequate antibiotic treatment of primary Group A Streptococcus infections.
- Early intervention can mitigate the risk of developing severe complications such as chronic kidney disease.
More Related Videos
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
08:04Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
Published on: February 8, 2019
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Acute Pyelonephritis I: Introduction
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury II: Pathophysiology